[go: up one dir, main page]

GB202119021D0 - Injectable and inhalable formulations - Google Patents

Injectable and inhalable formulations

Info

Publication number
GB202119021D0
GB202119021D0 GBGB2119021.0A GB202119021A GB202119021D0 GB 202119021 D0 GB202119021 D0 GB 202119021D0 GB 202119021 A GB202119021 A GB 202119021A GB 202119021 D0 GB202119021 D0 GB 202119021D0
Authority
GB
United Kingdom
Prior art keywords
injectable
inhalable formulations
inhalable
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2119021.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Small Pharma Ltd
Original Assignee
Small Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from TW110143066A external-priority patent/TWI891942B/en
Application filed by Small Pharma Ltd filed Critical Small Pharma Ltd
Publication of GB202119021D0 publication Critical patent/GB202119021D0/en
Priority to AU2022393234A priority Critical patent/AU2022393234A1/en
Priority to CA3238583A priority patent/CA3238583A1/en
Priority to US18/711,130 priority patent/US20250032450A1/en
Priority to JP2024529536A priority patent/JP2024540527A/en
Priority to US18/056,771 priority patent/US12318477B2/en
Priority to IL312859A priority patent/IL312859A/en
Priority to EP22818741.5A priority patent/EP4433049A1/en
Priority to KR1020247020007A priority patent/KR20240110836A/en
Priority to MX2024005955A priority patent/MX2024005955A/en
Priority to PCT/EP2022/082486 priority patent/WO2023089132A1/en
Priority to CL2024001452A priority patent/CL2024001452A1/en
Priority to ZA2024/03906A priority patent/ZA202403906B/en
Priority to CONC2024/0007518A priority patent/CO2024007518A2/en
Priority to US19/192,691 priority patent/US20250262145A1/en
Ceased legal-status Critical Current

Links

GBGB2119021.0A 2021-11-18 2021-12-24 Injectable and inhalable formulations Ceased GB202119021D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
MX2024005955A MX2024005955A (en) 2021-11-18 2022-11-18 Injectable and inhalable formulations.
PCT/EP2022/082486 WO2023089132A1 (en) 2021-11-18 2022-11-18 Injectable and inhalable formulations
IL312859A IL312859A (en) 2021-11-18 2022-11-18 Injectable and inhaled formulations
KR1020247020007A KR20240110836A (en) 2021-11-18 2022-11-18 Injectable and inhaled preparations
US18/711,130 US20250032450A1 (en) 2021-11-18 2022-11-18 Injectable and inhalable formulations
JP2024529536A JP2024540527A (en) 2021-11-18 2022-11-18 Injectable and inhaled preparations
US18/056,771 US12318477B2 (en) 2021-11-18 2022-11-18 Injectable and inhalable formulations
AU2022393234A AU2022393234A1 (en) 2021-11-18 2022-11-18 Injectable and inhalable formulations
EP22818741.5A EP4433049A1 (en) 2021-11-18 2022-11-18 Injectable and inhalable formulations
CA3238583A CA3238583A1 (en) 2021-11-18 2022-11-18 Injectable and inhalable formulations
CL2024001452A CL2024001452A1 (en) 2021-11-18 2024-05-15 Injectable and inhalable formulations
ZA2024/03906A ZA202403906B (en) 2021-11-18 2024-05-20 Injectable and inhalable formulations
CONC2024/0007518A CO2024007518A2 (en) 2021-11-18 2024-06-14 Injectable and inhalable formulations
US19/192,691 US20250262145A1 (en) 2021-11-18 2025-04-29 Injectable and inhalable formulations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW110143066A TWI891942B (en) 2020-12-01 2021-11-18 Deuterated compounds
PCT/EP2021/082227 WO2022117359A1 (en) 2020-12-01 2021-11-18 Deuterated or partially deuterated n,n-dimethyltryptamine compounds

Publications (1)

Publication Number Publication Date
GB202119021D0 true GB202119021D0 (en) 2022-02-09

Family

ID=80111767

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2119021.0A Ceased GB202119021D0 (en) 2021-11-18 2021-12-24 Injectable and inhalable formulations

Country Status (1)

Country Link
GB (1) GB202119021D0 (en)

Similar Documents

Publication Publication Date Title
IL287749A (en) Implantable drug delivery compositions and methods of use thereof
IL270812B1 (en) Solid compositions for oral administration comprising semaglutide and dapagliflozin and their use in medicine
ZA202400656B (en) 6-aminopyrazolopyrimidine compound and pharmaceutical use thereof
IL287628A (en) Injectable pharmaceutical compositions and uses thereof
IL291730A (en) Protein-macromolecule conjugates and methods of use thereof
ZA202105586B (en) Pharmaceutical delivery compositions and uses thereof
SG11202112129SA (en) Drug conjugates and methods of using same
PT4153133T (en) Injectable pharmaceutical compositions and uses thereof
IL288531A (en) Wide-spectrum antibacterial pharmaceutical formulations comprising lysozyme and methods of using the same
ZA202005143B (en) Oral formulations and uses thereof
IL291543A (en) Therapeutic formulations and uses thereof
IL271596A (en) Compositions for drug delivery and methods of use thereof
IL279877A (en) Ivosidenib forms and pharmaceutical compositions
GB202012742D0 (en) An inhalable medicament
GB202119021D0 (en) Injectable and inhalable formulations
ZA202408364B (en) Liquid-dispersible halopyruvate formulations and associated methods
EP3923916A4 (en) Injectable phenol formulations and methods of their use
PL3307275T3 (en) Injectable antibiotic formulations and use thereof
EP3893847A4 (en) Stable formulations of anesthetics and associated dosage forms
HK40116234A (en) Injectable and inhalable formulations
ZA202104261B (en) Combination pharmaceutical compositions and methods thereof
EP3615064A4 (en) Enriched cellular compositions and therapeutic use
IL292646A (en) Pharmaceutical combination and use thereof
GB202113944D0 (en) Injectable formulations
IL291451A (en) Subcutaneously injectable insulin formulations and methods of administration

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)